Pregnane glycoside multidrug-resistance modulators from Cynanchum wilfordii

被引:44
作者
Hwang, BY
Kim, SE
Kim, YH
Kim, HS
Hong, YS
Ro, JS
Lee, KS
Lee, JJ
机构
[1] Korea Res Inst Biosci & Biotechnol, Natl Prod Biosynth Res Unit, Taejon 305600, South Korea
[2] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
来源
JOURNAL OF NATURAL PRODUCTS | 1999年 / 62卷 / 04期
关键词
D O I
10.1021/np980479x
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
The methanol-soluble extracts of the roots of Cynanchum wilfordii showed a significant multidrug-resistance-reversing activity, and four known pregnane glycosides were isolated by bioassay-directed fractionation and separation. Their structures were identified as gagaminin 3-O-beta-D-cymaropyranosyl-(1-->4)-beta-D-oleandropyranosyl-(1-->4)-beta-D-cymaropyranosyl-(1-->4)-beta-D-cymaropyranoside (1), wilfoside K1N (2), wilfoside C1N (3), and cynauricuoside A (4). In particular, compound 1, at a concentration level of 1 mu M, was found to completely reverse the multidrug-resistance of KB-V1 and MCF7/ADR cells to adriamycin, vinblastine, and colchicine.
引用
收藏
页码:640 / 643
页数:4
相关论文
共 18 条
[1]
BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[2]
MECHANISM OF ACTION OF DEXNIGULDIPINE-HCL (B8509-035), A NEW POTENT MODULATOR OF MULTIDRUG-RESISTANCE [J].
HOFMANN, J ;
GEKELER, V ;
ISE, W ;
NOLLER, A ;
MITTERDORFER, J ;
HOFER, S ;
UTZ, I ;
GOTWALD, M ;
BOER, R ;
GLOSSMANN, H ;
GRUNICKE, HH .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (05) :603-609
[3]
SDZ PSC-833, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE - ITS POTENCY IN OVERCOMING P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE OF MURINE LEUKEMIA [J].
KELLER, RP ;
ALTERMATT, HJ ;
NOOTER, K ;
POSCHMANN, G ;
LAISSUE, JA ;
BOLLINGER, P ;
HIESTAND, PC .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) :593-597
[4]
Kim S.-E., 1997, OSTEOPOROSIS INT, V28, P174
[5]
5 NEW PREGNANE GLYCOSIDES FROM CYNANCHUM-TAIWANIANUM [J].
LIN, YL ;
LIN, TC ;
KUO, YH .
JOURNAL OF NATURAL PRODUCTS-LLOYDIA, 1995, 58 (08) :1167-1173
[6]
P-GLYCOPROTEIN EXPRESSION IN MALIGNANT-LYMPHOMA AND REVERSAL OF CLINICAL DRUG-RESISTANCE WITH CHEMOTHERAPY PLUS HIGH-DOSE VERAPAMIL [J].
MILLER, TP ;
GROGAN, TM ;
DALTON, WS ;
SPIER, CM ;
SCHEPER, RJ ;
SALMON, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :17-24
[7]
STEROID-HORMONES INHIBIT BINDING OF VINCA ALKALOID TO MULTIDRUG RESISTANCE RELATED P-GLYCOPROTEIN [J].
NAITO, M ;
YUSA, K ;
TSURUO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) :1066-1071
[8]
RADAL S, 1988, CANC CHEMOTHER PHARM, V21, P25
[9]
NEW COLORIMETRIC CYTOTOXICITY ASSAY FOR ANTICANCER-DRUG SCREENING [J].
SKEHAN, P ;
STORENG, R ;
SCUDIERO, D ;
MONKS, A ;
MCMAHON, J ;
VISTICA, D ;
WARREN, JT ;
BOKESCH, H ;
KENNEY, S ;
BOYD, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1107-1112
[10]
HIGH-DOSE ORAL TAMOXIFEN, A POTENTIAL MULTIDRUG-RESISTANCE-REVERSAL AGENT - PHASE-I TRIAL IN COMBINATION WITH VINBLASTINE [J].
TRUMP, DL ;
SMITH, DC ;
ELLIS, PG ;
ROGERS, MP ;
SCHOLD, SC ;
WINER, EP ;
PANELLA, TJ ;
JORDAN, VC ;
FINE, RL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) :1811-1816